Eckhard Guenther - Aeterna Zentaris Sr Germany
| AEZSDelisted Stock | USD 6.14 0.08 1.29% |
Insider
Eckhard Guenther is Sr Germany of Aeterna Zentaris
| Phone | 843 900 3223 |
| Web | https://www.zentaris.com |
Aeterna Zentaris Management Efficiency
The company has return on total asset (ROA) of (0.2996) % which means that it has lost $0.2996 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8171) %, meaning that it created substantial loss on money invested by shareholders. Aeterna Zentaris' management efficiency ratios could be used to measure how well Aeterna Zentaris manages its routine affairs as well as how well it operates its assets and liabilities.Aeterna Zentaris currently holds 277.57 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Aeterna Zentaris has a current ratio of 9.66, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Aeterna Zentaris' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Stephen Kilmer | Ibio Inc | N/A | |
| Alex Lugovoy | Adial Pharmaceuticals | N/A | |
| CPA CPA | Tonix Pharmaceuticals Holding | 50 | |
| Xiaoqin MD | Avenue Therapeutics | 49 | |
| Laxminarayan Bhat | Reviva Pharmaceuticals Holdings | 59 | |
| Carol Lizak | Jaguar Animal Health | 60 | |
| Robert Dudley | Transcode Therapeutics | 73 | |
| Donald Picker | Moleculin Biotech | 78 | |
| Melissa Berquist | Ibio Inc | N/A | |
| Catherine Fratila | Adial Pharmaceuticals | N/A | |
| Jacqueline Northcut | Moleculin Biotech | 62 | |
| David Sesin | Jaguar Animal Health | N/A | |
| DDS MS | Aditxt Inc | 59 | |
| CPA CPA | Aditxt Inc | 56 | |
| Margaret MD | Pulmatrix | 67 | |
| Jack Reich | Adial Pharmaceuticals | 75 | |
| Thomas III | Ibio Inc | 57 | |
| Pravin Chaturvedi | Jaguar Animal Health | 61 | |
| Peter MBA | Bio Path Holdings | 75 | |
| Alan MacKenzie | Bio Path Holdings | N/A | |
| Anna Moore | Transcode Therapeutics | 62 | |
Management Performance
| Return On Equity | -0.82 | |||
| Return On Asset | -0.3 |
Aeterna Zentaris Leadership Team
Elected by the shareholders, the Aeterna Zentaris' board of directors comprises two types of representatives: Aeterna Zentaris inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aeterna. The board's role is to monitor Aeterna Zentaris' management team and ensure that shareholders' interests are well served. Aeterna Zentaris' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aeterna Zentaris' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Klaus Paulini, CEO President | ||
| Amlie Mtivier, Assistant Sec | ||
| Eckhard Guenther, Sr Germany | ||
| ICDD MBA, CEO President | ||
| Giuliano Fratta, Senior CFO | ||
| Matthias Gerlach, Senior Production | ||
| Nicola MD, Chief Development | ||
| Michael Teifel, Vice President - Non-Clinical Sciences |
Aeterna Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aeterna Zentaris a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.82 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | 15.15 M | |||
| Shares Outstanding | 3.06 M | |||
| Shares Owned By Insiders | 1.32 % | |||
| Shares Owned By Institutions | 5.21 % | |||
| Number Of Shares Shorted | 5.27 K | |||
| Price To Earning | 15.42 X | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 7.60 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Aeterna Stock
If you are still planning to invest in Aeterna Zentaris check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aeterna Zentaris' history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Transaction History View history of all your transactions and understand their impact on performance |